Posted on 2011 05, 25 by bcg2
bcg2 Healthcare has picked up the launch of Avigra, from Viagra account incumbents M&C Saatchi. Avigra is the new brand for Pfizer’s “little blue pill”, to compete against a raft of expected generic brand competitors. ‘The business was awarded without a pitch’, says bcg2 Healthcare General Manager Stuart Ogden. “It’s quite an honour to be awarded the account for arguably, the world’s most recognisable pharmaceutical pill. We’re looking forward to taking the new brand in a different direction.”
Following the success of previous projects for Lion Nathan, bcg2 were asked to take the lead agency role for the most significant trans-Tasman brand launch for 2010. Te Hana, te reo for ‘to shine’, is a premium New Zealand sparkling wine brand available in three varieties: Sparkling Reserve Cuvée, Sparkling Rosé and Sparkling Sauvignon Blanc.
In July Audi launched the new Audi A8, its flagship model, in New Zealand. This brand new masterpiece is the height of luxury and lorded as one of the most technically advanced cars in the world, with many innovative new features.
